Published in Ophthalmologe on July 01, 2004
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res (2010) 1.39
Animal models of age related macular degeneration. Mol Aspects Med (2012) 1.39
CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits. Aging (Albany NY) (2010) 1.04
Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br J Ophthalmol (2005) 0.94
A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp Eye Res (2009) 0.91
[Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe]. Ophthalmologe (2005) 0.75
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci (1995) 4.97
Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) (1988) 4.47
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology (1995) 4.28
Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology (1993) 3.99
A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA (1996) 3.79
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol (1992) 2.71
Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci (2001) 2.54
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 2.27
Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol (2001) 2.27
Retinal and choroidal neovascularization. J Cell Physiol (2000) 2.20
Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol (2000) 2.19
Dietary fat and age-related maculopathy. Arch Ophthalmol (1995) 2.11
Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol (1995) 2.02
Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol (1999) 2.01
Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol (1999) 1.98
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci (2000) 1.65
Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology (1986) 1.62
Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci (1995) 1.61
VEGF localisation in diabetic retinopathy. Br J Ophthalmol (1998) 1.40
Animal models in research on retinal degenerations: past progress and future hope. Vision Res (2002) 1.33
Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol (2002) 1.33
Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology (1993) 1.29
Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol (2000) 1.18
Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr Eye Res (1999) 1.06
Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core. Am J Pathol (1986) 1.05
Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci (1997) 1.03
The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol (2000) 0.99
The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci (2001) 0.97
Pathologic changes in the retinal pigment epithelium and Bruch's membrane of fat-fed atherogenic mice. Curr Eye Res (2000) 0.93
[Biochemical and histochemical analysis of age related lipid deposits in Bruch's membrane]. Ophthalmologe (1994) 0.81
Correlation of blood-glucose control with oxidative metabolites in plasma and vitreous body of diabetic patients. Eur J Ophthalmol (2002) 0.75
Accessing genetic information with high-density DNA arrays. Science (1996) 13.89
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.96
Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61
The molecular architecture of focal adhesions. Annu Rev Cell Dev Biol (1995) 3.41
Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol (2009) 2.60
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol (2008) 2.24
Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci Lett (2000) 2.22
Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem (2000) 2.19
[Number of patients with chronic dyspnea in three German specialist practices]. Pneumologie (2012) 2.08
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant (2014) 2.02
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J (2004) 2.02
Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol (2008) 1.94
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol (2008) 1.88
Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol (2000) 1.73
Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. J Clin Invest (1997) 1.67
Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant. Clin Pharmacol Ther (2010) 1.57
Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med (2000) 1.57
Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology (2001) 1.54
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53
Intraparenchymal infusions of 192 IgG-saporin: development of a method for selective and discrete lesioning of cholinergic basal forebrain nuclei. J Neurosci Methods (1999) 1.52
Factors influencing breath condensate volume. Pneumologie (2001) 1.51
Location and type of mutation in the LIS1 gene do not predict phenotypic severity. Neurology (2007) 1.45
Combined choroidal and retinal ischemia during interferon therapy: indocyanine green angiographic and microperimetric findings. Arch Ophthalmol (2000) 1.45
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J (2009) 1.44
Functional imaging in PNH caused by a new FilaminA mutation. Neurology (2004) 1.43
[Correlation of TEI Index and invasive parameters of rightheart function in PAH]. Pneumologie (2004) 1.38
ARX mutations in X-linked lissencephaly with abnormal genitalia. Neurology (2003) 1.36
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol Dis (2010) 1.35
Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography. Br J Ophthalmol (2007) 1.28
[High-resolution optical coherence tomography to evaluate vitreomacular traction before and after membrane peeling]. Ophthalmologe (2008) 1.27
Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry (2009) 1.26
Value of polarisation-sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium. Br J Ophthalmol (2008) 1.23
"Motor circuit" gray matter changes in idiopathic cervical dystonia. Neurology (2003) 1.20
Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration. Br J Ophthalmol (2009) 1.20
Photodynamic therapy with verteporfin: a new treatment in ophthalmology. Semin Ophthalmol (2001) 1.16
Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography. Br J Ophthalmol (2010) 1.15
Transcranial color-coded real-time sonography in adults. Stroke (1990) 1.12
Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas. Neurology (2003) 1.12
Hypothalamic gray matter changes in narcoleptic patients. Nat Med (2002) 1.10
Photodynamic therapy of choroidal hemangioma: two case reports. Graefes Arch Clin Exp Ophthalmol (2000) 1.09
Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension. J Med Genet (2004) 1.08
Radial artery thrombosis following transradial coronary angiography: incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins. Clin Res Cardiol (2010) 1.08
[From the genome to the proteome]. Ophthalmologe (2001) 1.08
Analysis of breast milk to assess exposure to chlorinated contaminants in Kazakstan: high levels of 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in agricultural villages of southern Kazakstan. Environ Health Perspect (1998) 1.04
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond) (2012) 1.04
A filamin A splice mutation resulting in a syndrome of facial dysmorphism, periventricular nodular heterotopia, and severe constipation reminiscent of cerebro-fronto-facial syndrome. J Med Genet (2005) 1.04
Somatic mosaicism and variable penetrance in doublecortin-associated migration disorders. Neurology (2003) 1.03
Bosentan therapy for portopulmonary hypertension. Eur Respir J (2005) 1.02
Further clinical and genetic characterization of SPG11: hereditary spastic paraplegia with thin corpus callosum. Neuropediatrics (2006) 1.02
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol (1999) 1.01
The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol (2009) 1.01
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. Br J Ophthalmol (2008) 1.00
Calcified neurocysticercosis lesions trigger symptomatic inflammation during antiparasitic therapy. AJNR Am J Neuroradiol (2006) 0.99
Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Lung (2002) 0.98
Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol (2003) 0.98
[Three-dimensional imaging in central serous chorioretinopathy]. Ophthalmologe (2008) 0.97
Increased interleukin-6 in collected drainage blood after total knee arthroplasty: an association with febrile reactions during retransfusion. Acta Orthop Scand (2001) 0.96
Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. Neurosurgery (1992) 0.95
Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome. Neurology (2006) 0.95
First experimental and clinical results with transscleral optical coherence tomography. Ophthalmic Surg Lasers (2000) 0.95
Peripheral airway obstruction in primary pulmonary hypertension. Thorax (2002) 0.95
The emergency contraception collaborative prescribing experience in Washington State. J Am Pharm Assoc (Wash) (2001) 0.94
The isolation and characterization of monopyrroles from Serratia marcescens. Biochem Biophys Res Commun (1972) 0.94
Analysis of breast milk to assess exposure to chlorinated contaminants in Kazakstan: PCBs and organochlorine pesticides in southern Kazakstan. Environ Health Perspect (1997) 0.94
Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br J Ophthalmol (2005) 0.94
Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis. J Clin Invest (1991) 0.93
Aspergillus detection in bronchoscopically acquired material. Significance and interpretation. Mycoses (2001) 0.93
[Photodynamic therapy: extended indication]. Ophthalmologe (2003) 0.93
Central visual field impairment during and following cystoid macular oedema. Br J Ophthalmol (2007) 0.92
Interexaminer and intraexaminer reliability of the microperimeter MP-1. Eye (Lond) (2008) 0.91
Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. Br J Ophthalmol (2009) 0.91
Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: a case report. Leuk Res (2010) 0.91
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results. Eye (Lond) (2009) 0.91
Compliance in hemodialysis patients: a multivariate regression analysis. Nephron (1993) 0.91
[The role of Stratus OCT in anti-VEGF therapy. Qualitative and quantitative assessment of neovascular AMD]. Ophthalmologe (2008) 0.90
Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care (1989) 0.90
Precursor cells in mouse islets generate new beta-cells in vivo during aging and after islet injury. Endocrinology (2010) 0.89
Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye (Lond) (2008) 0.89
Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Am J Transplant (2007) 0.89
Biosynthesis of the 3-acetyl and 13(1)-oxo groups of bacteriochlorophyll a in the facultative aerobic bacterium, Rhodovulum sulfidophilum--the presence of both oxygenase and hydratase pathways for isocyclic ring formation. Eur J Biochem (1998) 0.88
Tracking the Response of Burkholderia cepacia G4 5223-PR1 in Aquifer Microcosms. Appl Environ Microbiol (1995) 0.88
Photodynamics of the bacteriochlorophyll-carotenoid system. 1. Bacteriochlorophyll-photosensitized oxygenation of beta-carotene in acetone. Photochem Photobiol (2001) 0.88
[New perspectives in diagnostic. High-resolution optical coherence tomography for age-related macular degeneration]. Ophthalmologe (2008) 0.87
Agenesis of the corpus callosum, abnormal genitalia and intractable epilepsy due to a novel familial mutation in the Aristaless-related homeobox gene. Neuropediatrics (2004) 0.87
Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2. Eye (Lond) (2010) 0.87
Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy (2008) 0.87
Reliability of atlas-derived coordinates in deep brain stimulation. Acta Neurochir (Wien) (2005) 0.87
[Chorioretinal anastomosis as unfavourable prognostic factor during photodynamic therapy]. Ophthalmologe (2003) 0.86
Isolated lissencephaly sequence and double-cortex syndrome in a German family with a novel doublecortin mutation. Neuropediatrics (2000) 0.85
[Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration]. Ophthalmologe (2007) 0.84
Molecular mechanisms of neuronal migration disorders, quo vadis? Curr Mol Med (2001) 0.84
Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Stem Cells (1999) 0.84
Carp preproinsulin cDNA sequence and evolution of insulin genes. Nucleic Acids Res (1983) 0.84
Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats. Acta Anaesthesiol Scand (2009) 0.84
Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol (2011) 0.84
Preweaning enrichment has no lasting effects on adult hippocampal neurogenesis in four-month-old mice. Genes Brain Behav (2002) 0.84
A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma. J Pharmacokinet Pharmacodyn (2007) 0.83
Clinical spectrum of muscle-eye-brain disease: from the typical presentation to severe autistic features. Acta Myol (2004) 0.83